Chewable Tablets Made From Momordica Charantia [Bitter Melon] A Hypothesis Driven Strategy For Managing Diabetes Mellitus

Abstract

Diabetes Mellitus, the metabolic disorder that causes persistently high blood sugar levels, is a major public health concern across the world. More than 61 million people in India deal with diabetes, earning the country the nickname "Capital of Diabetes." complications caused by diabetes. Phytochemicals and essential medications are abundant in plants, making them an excellent natural resource. The bitter melon, or Momordica charantia (MC), is a useful remedy for diabetes mellitus due to its high phytochemical content. One name for Momordica charantia is "vegetable insulin" due to the hypoglycemic effects caused by its alkaloids and peptides, which are similar to insulin and Charantin. Much has been said and written about bitter melon's action mechanism. Because of their slow disintegration or dissolving in the mouth, the active ingredient in medicated Momordica charantia lozenges is released gradually. This is due to the fact that the lozenges dosage form has a good oral retention time in, increases bioavailability, and decreases gastrointestinal irritation. Both topical and systemic administration are possible with this dose type. The development of chewable lozenges containing Momordica charantia as a medication for type 2 diabetes is central to our working hypothesis. The article touches on a few bits of data from bitter melon investigations, both in the pre-clinical and clinical stages. Multiple investigations in the fields of physiology, pharmacology, and biochemistry have provided credence to our theory. The paper also details the process that was utilized to create the chewable lozenges. Additionally, the essay has covered many bitter melon and herbal lozenge formulations that are available for purchase.